Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Upsher-Smith Laboratories

Tracked across 1 events · 6 articles · First seen Sep 15, 2026 · Last active Sep 15, 2026

Sentiment
0
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 0
Regulatory
Women are increasingly seeking testosterone therapy for menopause symptoms, but face prescription delays and denials at major pharmacies. There is no U.S.-approved testosterone product for women, though off-label use has surged 146% from January 2023…
Impact: Upsher-Smith declined to comment on developing women-specific testosterone products, leaving its strategy unclear.
Sep 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Upsher-Smith Laboratories live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.